Changes in myocardial total creatine (tCr) and triglyceride (TG) content have been linked to the pathogenesis of cardiomyopathy. An assessment of repeatability for absolute quantification of myocardial [tCr] and [TG] is required for 1H-MRS to be employed for longitudinal monitoring of therapeutic efficacy. This work reports intra- and inter-exam repeatability of [tCr] and [TG] measurements with 1H-MRS at 3 Tesla. Our results indicate that the repeatability of the 1H-MRS assay will be sufficient to detect a >50% depletion of the tCr pool, and >50% changes in myocardial TG levels with 95% confidence in a single subject.
This abstract and the presentation materials are available to members only; a login is required.